These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32057590)

  • 1. Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model.
    Dal Santo F; Jarratt-Barnham I; González-Blanco L; García-Portilla MP; Bobes J; Fernández-Egea E
    Eur Neuropsychopharmacol; 2020 Apr; 33():158-163. PubMed ID: 32057590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia.
    Costa-Dookhan KA; Rajji TK; Tran VN; Bowden S; Mueller DJ; Remington GJ; Agarwal SM; Hahn MK
    Sci Rep; 2021 Jan; 11(1):2004. PubMed ID: 33479273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine and global cognition in schizophrenia.
    Rajji TK; Uchida H; Ismail Z; Ng W; Mamo DC; Remington G; Pollock BG; Mulsant BH
    J Clin Psychopharmacol; 2010 Aug; 30(4):431-6. PubMed ID: 20631560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy.
    Costa-Dookhan KA; Agarwal SM; Chintoh A; Tran VN; Stogios N; Ebdrup BH; Sockalingam S; Rajji TK; Remington GJ; Siskind D; Hahn MK
    Expert Opin Drug Saf; 2020 Jan; 19(1):43-57. PubMed ID: 31770500
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients.
    Molins C; Carceller-Sindreu M; Navarro H; Carmona C; Piñeiro M; Martínez E; Álvarez E; Portella MJ
    Psychiatry Res; 2017 Dec; 258():153-157. PubMed ID: 29024893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma clozapine/N-desmethylclozapine and changes in basal forebrain-dorsolateral prefrontal cortex coupling in treatment-resistant schizophrenia.
    Sarpal DK; Blazer A; Wilson JD; Calabro FJ; Foran W; Kahn CE; Luna B; Chengappa KNR
    Schizophr Res; 2022 May; 243():170-177. PubMed ID: 35381515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with cognitive dysfunction in treatment-responsive and -resistant schizophrenia: A pilot cross-sectional study.
    Suzuki Y; Watanabe K; Kanno-Nozaki K; Horikoshi S; Ichinose M; Hirata Y; Kobayashi Y; Takeuchi S; Osonoe K; Hoshino S; Miura I
    J Psychiatr Res; 2024 Oct; 178():228-235. PubMed ID: 39163661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine.
    Rajji TK; Mulsant BH; Davies S; Kalache SM; Tsoutsoulas C; Pollock BG; Remington G
    Am J Psychiatry; 2015 Jun; 172(6):579-85. PubMed ID: 25859763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats.
    Prus AJ; Pehrson AL; Philibin SD; Wood JT; Vunck SA; Porter JH
    Psychopharmacology (Berl); 2009 Apr; 203(2):295-301. PubMed ID: 18685832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus.
    Ertuğrul A; Ozdemir H; Vural A; Dalkara T; Meltzer HY; Saka E
    Brain Res Bull; 2011 Feb; 84(2):144-50. PubMed ID: 21134422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of the in vivo metabolism of clozapine.
    Raedler TJ; Hinkelmann K; Wiedemann K
    Clin Neuropharmacol; 2008; 31(6):347-52. PubMed ID: 19050412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia.
    Vaquero-Baez M; Díaz-Ruíz A; Tristán-López L; Aviña-Cervantes C; Torner C; Ramírez-Bermúdez J; Montes S; Ríos C
    BMC Psychiatry; 2019 Oct; 19(1):295. PubMed ID: 31597566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of Change in Plasma Clozapine/N-desmethylclozapine Ratio with Cognitive Performance in Patients with Schizophrenia.
    Park R; Kim S; Kim E
    Psychiatry Investig; 2020 Nov; 17(11):1158-1165. PubMed ID: 33198433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between plasma levels of clozapine and N-desmethyclozapine as well as M1 receptor polymorphism with cognitive functioning and associated cortical activity in schizophrenia.
    Kır Y; Baskak B; Kuşman A; Sayar-Akaslan D; Özdemir F; Sedes-Baskak N; Süzen HS; Baran Z
    Psychiatry Res Neuroimaging; 2020 Sep; 303():111128. PubMed ID: 32593951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole saliva and plasma levels of clozapine and desmethylclozapine.
    Dumortier G; Lochu A; Zerrouk A; Van Nieuwenhuyse V; Colen de Melo P; Roche Rabreau D; Degrassat K
    J Clin Pharm Ther; 1998 Feb; 23(1):35-40. PubMed ID: 9756110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine treatment of childhood-onset schizophrenia: evaluation of effectiveness, adverse effects, and long-term outcome.
    Sporn AL; Vermani A; Greenstein DK; Bobb AJ; Spencer EP; Clasen LS; Tossell JW; Stayer CC; Gochman PA; Lenane MC; Rapoport JL; Gogtay N
    J Am Acad Child Adolesc Psychiatry; 2007 Oct; 46(10):1349-1356. PubMed ID: 17885577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
    Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
    Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
    Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
    CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-desmethylclozapine: is there evidence for its antipsychotic potential?
    Mendoza MC; Lindenmayer JP
    Clin Neuropharmacol; 2009; 32(3):154-7. PubMed ID: 19483482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lemborexant on pharmacokinetics of clozapine: A potential drug-drug interaction mediated by time-dependent inhibition of CYP3A4.
    Watanabe K; Misaka S; Kanno-Nozaki K; Chiyoda T; Suzuki Y; Sato A; Suto T; Kuroda J; Shimomura K; Miura I; Yabe H
    Br J Clin Pharmacol; 2024 Jan; 90(1):354-359. PubMed ID: 37596710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.